• / Free eNewsletters & Magazine
  • / My Account
Home>Stocks>First Data

First Data

  1. All
  2. Morningstar Articles
  3. Videos
  4. 3rd Party
  5. Investing
  1. KKR's Quarterly Profit Rises 29% -- 2nd Update

    KKR's Quarterly Profit Rises 29% -- 2nd Update

  2. Mack-Cali Realty Corporation Announces First Quarter Results

    Mack-Cali Realty Corporation Announces First Quarter Results

  3. ARIAD Announces Issuance of Key U.S. Patent on Brigatinib

    ARIAD Announces Issuance of Key U.S. Patent on Brigatinib

  4. Early Findings with KEYTRUDA® (pembrolizumab), Merck’s Anti-PD-1 Therapy, in Patients with Advanced Pleural Mesothelioma Presented at AACR Annual Meeting

    Early Findings with KEYTRUDA® (pembrolizumab), Merck’s Anti-PD-1 Therapy, in Patients with Advanced Pleural Mesothelioma Presented at AACR Annual Meeting

  5. Nephros Reports 2014 Fourth Quarter and Full Year Financial Results

    Nephros Reports 2014 Fourth Quarter and Full Year Financial Results

  6. Fitch Upgrades First Data's Sr Secured Issue Ratings to 'BB'; Affirms IDR at 'B'; Outlook Stable

    Fitch Upgrades First Data's Sr Secured Issue Ratings to 'BB'; Affirms IDR at 'B'; Outlook Stable

  7. 5 Key Questions for JPMorgan Investors

    Outperformance is increasingly unlikely.

  8. Fund Times: Pioneer Loses Star High-Yield Manager

    Plus, First Data buyout boosts funds, manager changes at Fidelity, and more.

  9. Some Steam for Global Growth in 2014

    Waning austerity measures and more trade will help, but tight lending and moderating growth in China may be headwinds.

  10. Market Mood Gyrations Continue on an Hourly Basis

    Even amid market mood swings courtesy of the Fed, steadily rising employment offset weak manufacturing data.

123
Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.